Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

JBSS vs ABVE: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

JBSS Wins Head-to-Head Institutional Verdict (5–1 across 6 Pillars · 10–0 Matrix Metrics)

JBSS Overall Winner 6-Pillar Tally: JBSS 5 – 1 ABVE Matrix Metrics: JBSS 10 – 0 ABVE

As of Nov 16, 2026, John B. Sanfilippo & SON (JBSS) is the stronger overall head-to-head candidate over Above Food Ingredients Inc. (ABVE) in the Tradestie Institutional Equity Comparison Engine, winning 10–0 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). JBSS carries a Unified Composite Score of 43.2/100 (HOLD) at $60.11 (9.8x Forward P/E, 6.7% operating margin), whereas ABVE carries 39.8/100 (SELL) at $0.11 (N/M Forward P/E, -23.2% operating margin).

  • Technical & Structure Timing Caution: JBSS is currently in a Breakdown options structure phase (RSI 49.3); meanwhile ABVE is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 28.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About JBSS vs ABVE
JBSS NASDAQ Head-to-Head Winner
John B. Sanfilippo & SON
Sugar & Confectionery Products
$60.11
+1.78% 1D
Market Cap $657.4M
TTM Revenue $1.17B
Forward P/E 9.8x
Beta / 30D Vol 0.22β · 65% Vol
Unified Composite Score
43.2 / 100 HOLD
Tech 51.0 Fund 56.0 Flow 59.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 49
RSI-14: 49.3 · SMA20: $59.72 · SMA50: $64.58
ABVE NASDAQ
Above Food Ingredients Inc. Common Stock
Food And Kindred Products
$0.11
-80.57% 1D
Market Cap $30.0M
TTM Revenue $295M
Forward P/E N/M
Beta / 30D Vol 4.10β · 310% Vol
Unified Composite Score
39.8 / 100 SELL
Tech 40.0 Fund 47.0 Flow 57.0 Mom 40.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -29.1%), weak momentum, RSI 28
RSI-14: 28.0 · SMA20: $0.55 · SMA50: $0.67

6-Pillar Scorecard Institutional Category Breakdown (JBSS 5 – 1 ABVE)

Columns: Metric · JBSS · ABVE
1. Valuation Multiples JBSS
Forward P/E 9.8x N/M
Trailing P/E 11.8x N/M
PEG Ratio 1.52x N/M
EV / Revenue 0.7x 0.1x
2. Growth & Scale JBSS
Revenue Growth (YoY) -3.5% -45.0%
Earnings Growth (YoY) -30.2% +0.0%
TTM Revenue (USD) $1.17B $295M
Market Cap $657.4M $30.0M
3. Profitability & Quality JBSS
Gross Margin 17.7% -2.8%
Operating Margin 6.7% -23.2%
Net Profit Margin 4.8% -23.4%
Return on Equity (ROE) 15.4% 0.0%
4. Balance Sheet & Cash Flow JBSS
Cash Generation (TTM) $30M -$40M EBITDA
Cash Flow Margin 2.6% -13.7% EBITDA Mgn
Net Cash / Leverage $140M Net Debt (0.38x D/E) 0.0% ROE
Dividend Yield 1.67% None (0.00%)
5. Options & Positioning JBSS
Options Structure Phase BREAKDOWN UNCLASSIFIED
Current IV / %ile 19.8% (<1st %ile) 148.3% (8th %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase ACCUMULATION · Neutral NEUTRAL · Markdown
6. R&D & Supply-Chain Moat ABVE
OpEx & R&D Intensity 11.0% of Rev ($128M) 20.4% of Rev ($60M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Packaged Foods Operator Packaged Foods Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: JBSS (10) vs ABVE (0)
Institutional Metric JBSS ABVE Criterion Row Edge
Market Capitalization
Scale
$657.4M $30.0M Larger Scale JBSS
Trailing P/E Ratio
Valuation
11.8x N/M Lower Multiple JBSS
Forward P/E Ratio
Valuation
9.8x N/M Lower Multiple JBSS
Revenue Growth (YoY)
Growth
-3.5% -45.0% Higher Growth JBSS
Operating Margin (TTM)
Profitability
6.7% -23.2% Higher Margin JBSS
Net Profit Margin
Profitability
4.8% -23.4% Higher Margin JBSS
Return on Equity (ROE)
Capital Efficiency
15.4% 0.0% Higher ROE JBSS
52-Week Range Position
Momentum
23% ($51–$92) 0% ($0–$7) Stronger Trend JBSS
Beta / 30D Volatility
Risk Regime
0.22β · 65% Vol 4.10β · 310% Vol Lower Realized Risk JBSS
Unified Institutional Score
Composite Signal
43.2 / 100 (HOLD) 39.8 / 100 (SELL) Higher Composite JBSS
Trailing 12M Revenue (USD)
Operating Scale
$1.17B $295M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
17.7% -2.8% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
1.52x PEG · 0.7x EV/Rev N/M PEG · 0.1x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$30M ($140M Net Debt (0.38x D/E)) -$40M EBITDA (0.0% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon JBSS +69.47 pp
JBSS: -9.71% · ABVE: -79.18%
3M Horizon JBSS +80.6 pp
JBSS: -10.83% · ABVE: -91.43%
6M Horizon JBSS +97.48 pp
JBSS: +1.81% · ABVE: -95.67%
1Y Horizon JBSS +103.22 pp
JBSS: +8.84% · ABVE: -94.38%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on JBSS vs ABVE. Trailing 12-month operating profitability (JBSS 6.7% vs ABVE -23.2%) and valuation multiples (JBSS 9.8x vs ABVE N/M Forward P/E) are benchmarked directly in Pillar 4 below.

JBSS ADR TTM Benchmark FX-Normalized USD
TTM Revenue$1.17B
Gross Margin17.7%
Op. Margin6.7%
ROE / Fwd P/E15.4% · 9.8x
ABVE ADR TTM Benchmark FX-Normalized USD
TTM Revenue$295M
Gross Margin-2.8%
Op. Margin-23.2%
ROE / Fwd P/E0.0% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
JBSS BREAKDOWN
95d in phase · OBV ACCUMULATION
Current IV 19.8%
IV Percentile <1st %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow ACCUMULATION
Exact JBSS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
ABVE UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 148.3%
IV Percentile 8th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact ABVE Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
JBSS Moat Profile Cyclical / Execution-Driven Positioning
Packaged Foods Operator
Competes within the Packaged Foods value chain with $657.4M market capitalization and 6.7% operating margin.
OpEx & R&D Reinvestment 11.0% of Rev ($128M)
90D Engineering Disclosures 0 Published
ABVE Moat Profile Cyclical / Execution-Driven Positioning
Packaged Foods Operator
Competes within the Packaged Foods value chain with $30.0M market capitalization and -23.2% operating margin.
OpEx & R&D Reinvestment 20.4% of Rev ($60M)
90D Engineering Disclosures 0 Published

Investor FAQ JBSS vs ABVE Key Questions & Quantitative Answers

As of Nov 16, 2026, John B. Sanfilippo & SON (JBSS) is the stronger overall head-to-head candidate over Above Food Ingredients Inc. (ABVE) in the Tradestie Institutional Equity Comparison Engine, winning 10–0 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). JBSS carries a Unified Composite Score of 43.2/100 (HOLD) at $60.11 (9.8x Forward P/E, 6.7% operating margin), whereas ABVE carries 39.8/100 (SELL) at $0.11 (N/M Forward P/E, -23.2% operating margin). Technical & Structure Timing Caution: JBSS is currently in a Breakdown options structure phase (RSI 49.3); meanwhile ABVE is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 28.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

JBSS leads the Growth & Scale pillar: JBSS posts -3.5% YoY revenue growth and -30.2% YoY earnings growth on $1.17B TTM revenue (17.7% gross margin, 6.7% operating margin), compared with ABVE at -45.0% YoY revenue growth and +0.0% YoY earnings growth on $295M TTM revenue (-2.8% gross margin, -23.2% operating margin). On trailing 12-month operating scale, JBSS generates $1.17B in USD-normalized revenue versus $295M for ABVE. In operating R&D and SG&A reinvestment, JBSS deploys 11.0% of Rev ($128M) (0 90-day corporate R&D disclosures) versus 20.4% of Rev ($60M) (0 disclosures) for ABVE.

JBSS screens cheaper on headline valuation multiples. JBSS trades at 9.8x Forward P/E, 11.8x Trailing P/E, 1.52x PEG, and 0.7x EV/Revenue (2.6% FCF margin), whereas ABVE trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.1x EV/Revenue (-13.7% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against JBSS (15.4% ROE) versus ABVE (0.0% ROE) capital efficiency.

In options market volatility and institutional positioning, JBSS carries 19.8% implied volatility (<1st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, ACCUMULATION on-balance volume, and sits in a BREAKDOWN options structure phase (0.22β · 65% Vol realized risk). By comparison, ABVE carries 148.3% implied volatility (8th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (4.10β · 310% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.